IGM Biosciences Inc

IGMS

Market Cap$312.48M

Close$

Compare IGM Biosciences

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
IGM Biosciences Inc	-1.3	0%	-147%	-	0.3
Market Avg	53.2	1.27%	29%	-	1.3
Healthcare Avg	29.7	1.32%	16%	7.3	1.3

$20.00

Target Price by Analysts

116.9% upsideIGM Biosciences Target Price Details

$0.79

Current Fair Value

91.4% downside

Overvalued by 91.4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$312.48 Million
Enterprise Value	$59.64 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-4.21
Beta	1.57
Outstanding Shares	33,636,592
Avg 30 Day Volume	310,194

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-1.32
PEG	8.24
Price to Sales	-
Price to Book Ratio	2.31
Enterprise Value to Revenue	28.33
Enterprise Value to EBIT	-0.23
Enterprise Value to Net Income	-1
Total Debt to Enterprise	0.69
Debt to Equity	0.25

Revenue Sources

No data

ESG Score

No data

About IGM Biosciences Inc